norethindrone has been researched along with Obesity in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (45.83) | 18.7374 |
| 1990's | 3 (12.50) | 18.2507 |
| 2000's | 7 (29.17) | 29.6817 |
| 2010's | 2 (8.33) | 24.3611 |
| 2020's | 1 (4.17) | 2.80 |
| Authors | Studies |
|---|---|
| Compton, SD; Rager, TL; Rosen, MW; Winfrey, OK | 1 |
| Archer, DF; Nakajima, ST; Pappadakis, J | 1 |
| Baskan, B; Demir, B; Haberal, A; Kandemir, O; Karabulut, E; Ozturkoglu, E; Solaroglu, A | 1 |
| Weisberg, E | 1 |
| Bialer, M; Doose, DR; Jacobs, D; Padmanabhan, M; Schwabe, S; Wang, SS | 1 |
| Aytan, H; Kelekci, S; Mollamahmutoglu, L; Oguz, S; Sargin, A; Tapisiz, OL | 1 |
| Bozkaya, H; Okumuş, B; Osmanağaoğlu, MA; Osmanağaoğlu, S; Osmanağaoğlu, T | 1 |
| Grewal, S; Iroh Tam, PY; Richardson, M | 1 |
| Elder, MG; Fotherby, K; Hamawi, A; Howard, G; Trayner, I | 1 |
| Fotherby, K; Koetsawang, S | 1 |
| Arner, P; Bergqvist, A; Carlström, K; Ek, I; Reynisdottir, S; Wahrenberg, H | 1 |
| Højgaard, L; Ottesen, B; Rosenfalck, AM; Sørensen, MB | 1 |
| Nerbrand, C; Nordström, L; Nyberg, P; Samsioe, G | 1 |
| Hommel, G; Muck, BR | 1 |
| Dunn, FG; Fife, R; Jones, JV | 1 |
| Manusharova, RA | 1 |
| Hamberger, L; Kim-Björklund, T; Landgren, BM | 1 |
| Berger, W; Chabot, V; Stamm, H | 1 |
| Hodges, RE | 1 |
| Di Paola, G; Marti, M; Nicholson, R; Puchulu, F; Robin, M | 1 |
| Ostergaard, E | 1 |
| Diddle, AW; Semmer, JR | 1 |
| Duffy, T; Phillips, N | 1 |
| Rakoff, AE | 1 |
9 trial(s) available for norethindrone and Obesity
| Article | Year |
|---|---|
Body mass index does not affect the efficacy or bleeding profile during use of an ultra-low-dose combined oral contraceptive.
Topics: Adolescent; Adult; Amenorrhea; Body Mass Index; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Estrogens; Ethinyl Estradiol; Female; Humans; Menstruation; Metrorrhagia; Middle Aged; Norethindrone; Norethindrone Acetate; Obesity; Pregnancy; Pregnancy, Unplanned; Young Adult | 2016 |
The effects of estrogen therapy and estrogen combined with different androgenic progestins on carbohydrate and lipid metabolism in overweight-obese younger postmenopausal women.
Topics: Blood Glucose; Carbohydrate Metabolism; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Female; Humans; Insulin Resistance; Lipid Metabolism; Medroxyprogesterone Acetate; Nandrolone; Norethindrone; Norethindrone Acetate; Obesity; Progesterone Congeners; Prospective Studies | 2008 |
Effect of topiramate or carbamazepine on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in healthy obese and nonobese female subjects.
Topics: Administration, Oral; Adult; Anticonvulsants; Area Under Curve; Body Mass Index; Carbamazepine; Contraceptives, Oral, Combined; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Drug Interactions; Enzyme Induction; Ethinyl Estradiol; Female; Fructose; Humans; Mestranol; Metabolic Clearance Rate; Norethindrone; Obesity; Topiramate | 2003 |
The role of hormone replacement therapy in endometrial polyp formation.
Topics: Adult; Contraceptives, Oral, Synthetic; Double-Blind Method; Endometrium; Estradiol; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Hysteroscopy; Medroxyprogesterone; Menopause; Middle Aged; Norethindrone; Norpregnenes; Obesity; Polyps; Prospective Studies; Recurrence; Regression Analysis | 2005 |
Effect of different preparations of hormone therapy on lipid and glucose metabolism, coagulation factors, and bone mineral density in overweight and obese postmenopausal women.
Topics: Adult; Aged; Blood Coagulation Factors; Blood Glucose; Body Mass Index; Bone Density; Contraceptives, Oral, Synthetic; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Lipids; Medroxyprogesterone; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Obesity; Overweight; Pharmaceutical Preparations; Postmenopause | 2005 |
Divergent effects of weight reduction and oral anticonception treatment on adrenergic lipolysis regulation in obese women with the polycystic ovary syndrome.
Topics: Adipocytes; Adipose Tissue; Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Adult; Contraceptives, Oral, Combined; Contraceptives, Oral, Sequential; Diet, Reducing; Estradiol Congeners; Estrogens; Ethinyl Estradiol; Female; Humans; Lipolysis; Norethindrone; Obesity; Polycystic Ovary Syndrome; Radioligand Assay; Sympathetic Nervous System; Weight Loss | 1999 |
Obesity and sarcopenia after menopause are reversed by sex hormone replacement therapy.
Topics: Absorptiometry, Photon; Adipose Tissue; Body Composition; Bone Density; Cross-Over Studies; Double-Blind Method; Estradiol; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Muscular Atrophy; Norethindrone; Obesity; Postmenopause; Progesterone Congeners | 2001 |
Effects of a lipid lowering fibrate and hormone replacement therapy on serum lipids and lipoproteins in overweight postmenopausal women with elevated triglycerides.
Topics: Administration, Oral; Cardiovascular Diseases; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Estradiol; Estrogen Replacement Therapy; Female; Gemfibrozil; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipoproteins; Middle Aged; Norethindrone; Obesity; Postmenopause; Treatment Outcome; Triglycerides | 2002 |
Oral contraceptive medication and glucose metabolism: long-term treatment.
Topics: Adult; Blood Glucose; Cholesterol; Clinical Trials as Topic; Contraceptives, Oral; Diabetes Mellitus; Ethinyl Estradiol; Female; Glucose; Glucose Tolerance Test; Humans; Middle Aged; Norethindrone; Obesity; Pregnancy; Triglycerides | 1974 |
15 other study(ies) available for norethindrone and Obesity
| Article | Year |
|---|---|
Norethindrone dosing for adequate menstrual suppression in adolescents.
Topics: Adolescent; Female; Humans; Menorrhagia; Norethindrone; Norethindrone Acetate; Obesity; Retrospective Studies | 2023 |
Contraceptive options for women in selected circumstances.
Topics: Adolescent; Adult; Anemia; Breast Diseases; Cardiovascular Diseases; Condoms; Contraception; Contraceptive Agents, Female; Contraindications; Desogestrel; Diabetes Mellitus; Drug Combinations; Drug Implants; Epilepsy; Ethinyl Estradiol; Female; Heart Valve Diseases; Humans; Hypertension; Inflammatory Bowel Diseases; Injections; Intrauterine Devices; Levonorgestrel; Liver Diseases; Lupus Erythematosus, Systemic; Medroxyprogesterone Acetate; Migraine Disorders; Norethindrone; Norgestrel; Obesity; Patient Preference; Pregnancy; Progestins; Stroke; Young Adult | 2010 |
Fatal case of bilateral internal jugular vein thrombosis following IVIg infusion in an adolescent girl treated for ITP.
Topics: Adolescent; Anemia, Iron-Deficiency; Anticoagulants; Brain Edema; Combined Modality Therapy; Dexamethasone; Ethinyl Estradiol; Fatal Outcome; Female; Heparin; Humans; Immunoglobulins, Intravenous; Infusions, Intravenous; Jugular Veins; Mannitol; Metrorrhagia; Norethindrone; Obesity; Purpura, Thrombocytopenic, Idiopathic; Thrombectomy; Thrombolytic Therapy; Venous Thrombosis | 2008 |
Effect of injectable norethisterone oenanthate (Norigest) on blood lipid levels.
Topics: Adult; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Contraceptive Agents, Female; Female; Humans; Lipids; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Middle Aged; Norethindrone; Obesity; Smoking | 1982 |
Metabolism of injectable formulations of contraceptive steroids in obese and thin women.
Topics: Adult; Estradiol; Female; Humans; Injections, Intramuscular; Medroxyprogesterone; Norethindrone; Obesity; Progesterone; Time Factors | 1982 |
[Effect of oral contraceptives on plasma insulin and blood glucose levels after long term use (author's transl)].
Topics: Adult; Age Factors; Blood Glucose; Contraceptives, Oral; Contraceptives, Oral, Hormonal; Diabetes Mellitus; Ethinyl Estradiol; Female; Glucose Tolerance Test; Humans; Insulin; Lynestrenol; Mathematics; Megestrol; Mestranol; Middle Aged; Norethindrone; Norgestrel; Obesity; Time Factors | 1976 |
Malignant hypertension associated with use of oral contraceptives.
Topics: Adult; Contraceptives, Oral; Drug Combinations; Ethinyl Estradiol; Female; Humans; Hypertension, Malignant; Norethindrone; Obesity | 1975 |
[The treatment of the climacteric syndrome in women suffering from Itsenko-Cushing disease and primary obesity].
Topics: Adrenal Glands; Bromocriptine; Climacteric; Combined Modality Therapy; Cushing Syndrome; Female; Humans; Hypothalamo-Hypophyseal System; Middle Aged; Norethindrone; Obesity; Ovary; Syndrome | 1992 |
Is the contraceptive effect of 300 micrograms of norethisterone mainly peripheral or central?
Topics: Adult; Corpus Luteum; Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Norethindrone; Obesity; Ovarian Follicle; Ovary; Ovulation; Pituitary Gland, Anterior; Progesterone; Reference Values | 1992 |
[Guidelines of the Swiss Diabetic Association on diabetes and contraception].
Topics: Blood Glucose; Contraceptives, Oral, Hormonal; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Estrogens; Female; Humans; Norethindrone; Norgestrel; Obesity; Pregnancy; Pregnancy in Diabetics; Societies, Medical; Switzerland | 1986 |
Nutrition and "the pill".
Topics: Chlormadinone Acetate; Contraceptives, Oral; Demography; Dimethisterone; Ethynodiol Diacetate; Female; Humans; Hypertension; Medroxyprogesterone; Norethindrone; Norethynodrel; Norgestrel; Nutrition Disorders; Nutritional Physiological Phenomena; Obesity; Pregnancy; Pregnancy Complications; Pyridoxine; Tryptophan | 1971 |
Oral contraceptives and carbohydrate metabolism.
Topics: Adult; Chlormadinone Acetate; Contraceptives, Oral; Diabetes Mellitus; Dietary Carbohydrates; Estradiol; Female; Glucose Tolerance Test; Humans; Mestranol; Middle Aged; Norethindrone; Obesity; Prednisone | 1968 |
Oral anticonception. Side effects and risks.
Topics: Acne Vulgaris; Contraceptives, Oral; Depression; Estrogens; Feeding and Eating Disorders; Female; Hair; Headache; Humans; Leukorrhea; Libido; Liver; Lynestrenol; Megestrol; Menstruation Disturbances; Mestranol; Nausea; Neoplasms; Norethindrone; Norethynodrel; Obesity; Ovulation; Premenstrual Syndrome; Progesterone; Skin; Thrombophlebitis; Vagina; Veins; Voice; Water-Electrolyte Balance | 1969 |
One-hour glucose tolerance in relation to the use of contraceptive drugs.
Topics: Adult; Age Factors; Blood Glucose; Contraceptives, Oral; Diabetes Mellitus; Dimethisterone; Ethynodiol Diacetate; Female; Glucose Tolerance Test; Humans; Medroxyprogesterone; Mestranol; Norethindrone; Norethynodrel; Norgestrel; Obesity; Time Factors | 1973 |
Menstrual disorders of the adolescent.
Topics: Adolescent; Amenorrhea; Child; Clomiphene; Diagnosis, Differential; Environment; Female; Hirsutism; Humans; Hypothyroidism; Menstruation Disturbances; Norethindrone; Obesity; Stilbenes | 1967 |